Role of NleH, a Type III Secreted Effector from Attaching and Effacing Pathogens, in Colonization of the Bovine, Ovine, and Murine Gut by Hemrajani, Cordula et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Role of NleH, a Type III Secreted Effector from Attaching and
Effacing Pathogens, in Colonization of the Bovine, Ovine, and
Murine Gut
Citation for published version:
Hemrajani, C, Marches, O, Wiles, S, Girard, F, Dennis, A, Dziva, F, Best, A, Phillips, AD, Berger, CN,
Mousnier, A, Crepin, VF, Kruidenier, L, Woodward, MJ, Stevens, MP, La Ragione, RM, MacDonald, TT &
Frankel, G 2008, 'Role of NleH, a Type III Secreted Effector from Attaching and Effacing Pathogens, in
Colonization of the Bovine, Ovine, and Murine Gut' Infection and Immunity, vol. 76, no. 11, pp. 4804-4813.
DOI: 10.1128/IAI.00742-08
Digital Object Identifier (DOI):
10.1128/IAI.00742-08
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Infection and Immunity
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
INFECTION AND IMMUNITY, Nov. 2008, p. 4804–4813 Vol. 76, No. 11
0019-9567/08/$08.000 doi:10.1128/IAI.00742-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Role of NleH, a Type III Secreted Effector from Attaching and Effacing
Pathogens, in Colonization of the Bovine, Ovine, and Murine Gut
Cordula Hemrajani,1 Olivier Marches,1 Siouxsie Wiles,1 Francis Girard,1 Alison Dennis,2
Francis Dziva,3 Angus Best,4 Alan D. Phillips,5 Cedric N. Berger,1 Aurelie Mousnier,1
Valerie F. Crepin,1 Laurens Kruidenier,6 Martin J. Woodward,4 Mark P. Stevens,3
Roberto M. La Ragione,4 Thomas T. MacDonald,2 and Gad Frankel1*
Division of Cell and Molecular Biology, Imperial College London, London SW7 2AZ, United Kingdom1; Institute of Cell and
Molecular Science, Barts and the London School of Medicine and Dentistry, London E1 2AT, United Kingdom2; Division of
Microbiology, Institute for Animal Health, Compton, Newbury, Berkshire RG20 7NN, United Kingdom3; Department of
Food & Environmental Safety, Veterinary Laboratories Agency (Weybridge), Surrey KT15 3NB, United Kingdom4;
Centre for Paediatric Gastroenterology, Royal Free Hospital, London, United Kingdom5; and
Immuno-Inflammation CEDD, GlaxoSmithKline Medicines Research Centre, Stevenage,
Hertfordshire SG1 2NY, United Kingdom6
Received 12 June 2008/Returned for modification 22 July 2008/Accepted 16 August 2008
The human pathogen enterohemorrhagic Escherichia coli (EHEC) O157:H7 colonizes human and animal gut
via formation of attaching and effacing lesions. EHEC strains use a type III secretion system to translocate a
battery of effector proteins into the mammalian host cell, which subvert diverse signal transduction pathways
implicated in actin dynamics, phagocytosis, and innate immunity. The genomes of sequenced EHEC O157:H7
strains contain two copies of the effector protein gene nleH, which share 49% sequence similarity with the gene
for the Shigella effector OspG, recently implicated in inhibition of migration of the transcriptional regulator
NF-B to the nucleus. In this study we investigated the role of NleH during EHEC O157:H7 infection of calves
and lambs. We found that while EHEC nleH colonized the bovine gut more efficiently than the wild-type
strain, in lambs the wild-type strain exhibited a competitive advantage over the mutant during mixed infection.
Using the mouse pathogen Citrobacter rodentium, which shares many virulence factors with EHEC O157:H7,
including NleH, we observed that the wild-type strain exhibited a competitive advantage over the mutant during
mixed infection. We found no measurable differences in T-cell infiltration or hyperplasia in colons of mice
inoculated with the wild-type or the nleH mutant strain. Using NF-B reporter mice carrying a transgene
containing a luciferase reporter driven by three NF-B response elements, we found that NleH causes an
increase in NF-B activity in the colonic mucosa. Consistent with this, we found that the nleHmutant triggered
a significantly lower tumor necrosis factor alpha response than the wild-type strain.
The human diarrheal pathogens enteropathogenic Esche-
richia coli (EPEC) and enterohemorrhagic E. coli (EHEC)
(31) and the murine pathogen Citrobacter rodentium (reviewed
in reference 28) colonize the host gastrointestinal tract via
attaching and effacing (A/E) lesions, which are characterized
by intimate adhesion to intestinal epithelia and localized ef-
facement of brush border microvilli (21). EPEC was the first
type of E. coli to be associated with human disease and is a
major cause of infantile diarrhea in developing countries (re-
viewed in reference 2), while EHEC (O157 and non-O157
strains) is prevalent in developed countries and causes a wide
spectrum of illnesses ranging from mild diarrhea to severe
diseases such as hemorrhagic colitis and hemolytic uremic syn-
drome mediated by Shiga toxins (31).
EPEC, EHEC, and C. rodentium harbor the locus of entero-
cyte effacement (LEE) pathogenicity island, which is necessary
for A/E lesion formation in vivo (26). The LEE encodes sev-
eral gene regulators, the outer membrane adhesin intimin (18),
the structural components of a type III secretion system
(T3SS) (17), chaperones, and translocator and several effector
proteins, including Tir (19), Map, EspG, EspF, and EspH
(reviewed in reference 12), that are injected into enterocytes
via the T3SS and differentially modulate cellular actin dynam-
ics in vitro.
In addition, EPEC, EHEC, and C. rodentium use the LEE-
encoded T3SS to inject a large number of effectors which are
encoded by genes that are scattered around the bacterial ge-
nome, carried mainly on prophages and genomic islands (8).
Among these effectors are Cif (which causes irreversible cell
cycle arrest at the G2/M transition) (24), EspJ (which is in-
volved in inhibition of receptor-mediated phagocytosis) (23),
TccP/EspFU and TccP2 (which can activate N-WASP) (1, 13,
39), EspI/NleA (which affects exocytosis) (16, 29), and NleH of
unknown function (34).
EHEC infection in humans frequently results from direct or
indirect contact with ruminant feces; however, the molecular
mechanisms underlying colonization of reservoir hosts are ill
defined. The LEE-carried genes required for A/E lesion for-
mation (e.g., those for Tir and intimin) play pivotal roles in
colonization of such hosts by EHEC O157:H7 (4, 7, 37), and
structural components of the T3SS were found by signature-
tagged mutagenesis to be required for colonization of calves by
EHEC O157:H7 and O26:H (9, 36). In addition to Tir, EspK
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has been shown to influence colonization of the bovine intes-
tine (38), while Map (9), TccP/EspFU (37), and NleD (25) had
no measurable effect. The roles of other T3SS effectors in
colonization of ruminants are not known.
C. rodentium is a natural mouse pathogen that, while causing
colonic hyperplasia, shares many virulence factors with EPEC
and EHEC (reviewed in reference 28). Following inoculation
via the oral route, bacteria colonize the colon, typically peaking
at day 9 before clearance at around day 17 (27). Recently we
refined the C. rodentium mouse model by developing noninva-
sive real-time bioluminescence imaging (BLI) to monitor in-
fection dynamics and tissue tropism in vivo (41). Using this
method, we have shown that C. rodentium first targets the
murine cecal patch and rectum before the infection spreads to
the large intestine.
The genome sequences of EHEC O157:H7 strains EDL933
and Sakai, EPEC strain E2348/69, and C. rodentium strain
ICC168 revealed that EHEC and EPEC contain two nleH
alleles (34; A. Iguchi et al., unpublished data), while C. roden-
tium harbors only one nleH gene. NleH shares 49% sequence
similarity with the Shigella flexneri T3SS serine/threonine ki-
nase effector protein OspG, which prevents ubiquitination and
subsequent degradation of phospho-IB and downstream ac-
tivation of the transcriptional factor NF-B, possibly via the
phosphorylation of the E3 ubiquitin ligase SCF-TrCP (Skp-
Cullin-F box protein) complex (20). NF-B proteins are tran-
scriptional factors that, when activated, control the transcrip-
tion of a large number of genes, many of which are involved in
the immune (inflammatory) response. The similarities between
NleH and OspG prompted us to investigate its role in coloni-
zation and activation of the NF-B pathway in vivo.
MATERIALS AND METHODS
Bacterial strains, plasmids, and primers. The bacterial strains, plasmids, and
primers used in this study are described in Tables 1, 2, and 3, respectively.
Bacteria were grown at 37°C in Luria-Bertani (LB) broth or agar supplemented
with ampicillin (100 g ml1), chloramphenicol (25 g ml1), kanamycin (50 g
ml1), and nalidixic acid (Nal) (15 to 25 g ml1) as appropriate. C. rodentium
ICC169 nleH, luminescent C. rodentium ICC180 nleH, and EHEC O157:H7
85-170 Nalr nleH1 nleH2 mutant strains (strains ICC229, ICC285, and
ICC232, respectively) were generated using the one-step PCR  Red-mediated
mutation protocol (6) (Table 1). Primers 1 and 2 (Table 3) were used to amplify
the kanamycin cassette in pKD4 for deletion of nleH in ICC169. Primers 3 and
4 were used to amplify the chloramphenicol cassette in pKD3 for deletion of
nleH in ICC180. For construction of the EHEC O157:H7 85-170 Nalr nleH1
nleH2 mutant, primers 5 and 6 for nleH1 and 7 and 8 for nleH2 were used for
amplification of the kanamycin cassette from pKD4. Prior to deletion of nleH1
from 85-170 nleH2, the kanamycin cassette was deleted as described previously
(6) using the pCP20 vector (3).
The PCR product of the resistance cassette, flanked by approximately 50 bp of
nleH, was digested with DpnI and the cassette electroporated into the recipient
strains carrying pKD46, encoding the  Red recombinase. Mutants were selected
on selective LB plates with kanamycin or chloramphenicol. Recombinant clones
were cured of pKD46 and the mutation confirmed by PCR using primers flanking
nleH and primers within the antibiotic resistance gene. Growth curves have
confirmed that the mutant and wild-type stains have identical growth rates in LB
and minimal media. Mutations of the nleH1 and nleH2 genes created using the
same method in EPEC strains were successfully complemented in trans during in
vitro studies.
Oral inoculation of calves. All animal experiments were performed in accor-
dance with the Animals (Scientific Procedures) Act 1986 and were approved by
the local Ethical Review Committee. Groups of four 12-day-old Friesian bull
calves were separately inoculated with approximately 1010 CFU of wild-type
85-170 Nalr or 85-170 Nalr nleH1 nleH2 as described previously by Stevens
et al. (33). The magnitude and duration of fecal excretion of the bacteria were
followed daily for 14 days. Wild-type and mutant bacteria were enumerated by
plating of triplicate serial dilutions of fresh feces collected by rectal palpation
onto sorbitol-MacConkey agar supplemented with potassium tellurite (2.5 mg
ml1) (T-SMAC) containing 25 g ml1 Nal (T-SMAC-Nal) and onto T-SMAC-
Nal containing 50 g ml1 kanamycin, respectively. Recovery of wild-type and
mutant bacteria was confirmed by PCR from selected colonies using nleH-
flanking primers. The sensitivity of detection was 102 CFU/g. Fecal excretion
data were statistically analyzed for the effect of mutation by means of an F test,
with the data taken as repeated measurements and the animal as a covariant
(Proc Mixed, Statistical Analysis System 1995; SAS Institute, Cary, NC). P values
of 	0.05 were considered significant.
Oral inoculation of lambs. Fifteen 6-week-old crossbred lambs were randomly
divided into three equal groups, supplied with food and water ad libitum, and
confirmed to be free of E. coli O157:H7 by enrichment and O157 immunomag-
netic separation. All lambs were housed in biosecure containment level 2 ac-
commodations. Each group was housed in a separate room with its own air
handling. The animals were visited by experienced staff, who changed protective
clothing between groups. Five lambs were each dosed orally with 109 CFU of
either wild-type 85-170 Nalr or the isogenic nleH1 nleH2 mutant separately, or
with wild-type 85-170 Nalr and the nleH1 nleH2 mutant together, suspended
in 10 ml of 0.1 M phosphate-buffered saline (PBS) (pH 7.4). Approximately 24 h
after oral inoculation and as required thereafter for up to 28 days, rectal fecal
samples from each lamb were collected for direct plating onto SMAC supple-
mented with either 15 g of Nal/ml or 25 g of kanamycin/ml. Samples that were
O157 negative on direct plating were enriched in buffered peptone water for 6 h
at 37°C and then plated onto SMAC plates supplemented with the appropriate
TABLE 1. Strains
Species and
strain Characteristics
a Source or
reference
C. rodentium
ICC169 Spontaneous Nalr mutant of wild-type
C. rodentium
40
ICC229 ICC169 NleH1 (Kanr) This study
ICC180 Bioluminescent strain harboring the
Photorhabdus luxCDABE operon
(Kanr)
40
ICC285 ICC180 NleH1 (Cmr) This study
E. coli
85-170 Spontaneous Stx1 and Stx2 EHEC
O157:H7 strain
35
85-170 Nalr Spontaneous Nalr derivative of 85-170 33
ICC232 85-170 Nalr NleH1NleH2 (Nalr
Kanr Cmr)
This study
ICC299 Commensal strain isolated from the
cecum of a C57BL/6 mouse
This study
a Kanr, Cmr, and Nalr, kanamycin, chloramphenicol, and nalidixic acid resis-
tant, respectively.
TABLE 2. Plasmids
Plasmid Characteristics Source orreference
pKD3 oriRg blaM; Cmr cassette flanked
by FRT sites
6
pKD4 oriRg blaM; Kanr cassette flanked
by FRT sites
6
pKD46 ori101 repA101(ts) araBp-gam-
bet-exo blaM
6
pCP20 FLP synthesis under thermal
control
3
pET28-a His6 tag expression vector Novagen
pET:nleH1 Derivative of pET28-a expressing
NleH1-His6
This study
pET:nleH1K159A Derivative of pET28-a expressing
NleH1K159A-His6
This study
VOL. 76, 2008 ROLE OF NleH IN EHEC AND C. RODENTIUM INFECTION 4805
antibiotic. Representative colonies were confirmed to be E. coli O157 by latex
agglutination (Oxoid). For coinfection studies, the competitive index (CI) was
calculated; it is defined as the ratio between the mutant and wild-type strains
within the output (bacteria recovered from the host after infection) divided by
their ratio within the input (initial inoculum). For this experiment, the input ratio
was 1:1. The null hypothesis that CI 
 1 was tested by a two-sided t test.
Murine models. Specific-pathogen-free female 6- to 8-week-old mice were
used in this study. Wild-type inbred C57BL/6 and DBA-1 mice were purchased
from Harlan UK Ltd. (Bicester, United Kingdom), while the transgenic light-
producing animal model DBA-1 NF-B-luc (Oslo) (P/N 119335) was purchased
from Xenogen-Caliper Corp. (Alameda, CA). The transgenic light-producing
animal model NF-B-RE-luc (Oslo)-Xen, commonly called NF-B-RE-luc
(Oslo), carries a transgene containing three NF-B responsive-element (RE)
sites from the immunoglobulin  light-chain promoter and modified firefly lu-
ciferase cDNA. All animals were housed in individually HEPA-filtered cages
with sterile bedding and free access to sterilized food and water. Independent
experiments were performed at least twice (but only once for histology) using at
least four mice per group.
Oral infection of mice, harvesting and collection of tissues, and bacterial stool
counts. Mice were orally inoculated using a gavage needle with 200 l of over-
night LB-grown bacterial suspension in PBS (5  109 CFU). The number of
viable bacteria used as the inoculum was determined by retrospective plating
onto LB agar containing antibiotics. Stool samples were recovered aseptically at
various time points after inoculation and the number of viable bacteria per gram
of stool determined after homogenization at 0.1g ml1 in PBS and plating onto
LB agar containing the appropriate antibiotics. At selected time intervals postin-
fection, blood was collected by cardiac puncture and mice were sacrificed by
cervical dislocation. Sections of distal colon were collected and snap frozen in
liquid nitrogen before storage at 70°C prior to analysis. For coinfection studies,
the CI was calculated as described previously by Mundy et al. (30). For this
experiment, the input ratio of wild-type strain to mutant strain was approximately
1:2. The null hypothesis that CI 
 1 was tested by a nonparametric Wilcoxon
two-tailed test using the GraphPad InStat software (GraphPad Software Inc.,
San Diego, CA).
In vivo BLI. Prior to imaging, the abdominal region of each mouse was
depilated to minimize any potential signal impedance by melanin within pig-
mented skin and fur. Bioluminescence (photons s1 cm2 sr1) from living
infected animals was measured after gaseous anesthesia with isofluorane using
the IVIS50 camera system (Xenogen-Caliper Corp., Alameda, CA). The sample
shelf was set to position D (field of view, 15 cm). A photograph (reference image)
was taken under low illumination prior to quantification of photons emitted from
strain ICC180 at a binning of 4 over 1 to 10 min using the software program
Living Image (Xenogen-Caliper Corp.) as an overlay on Igor (Wavemetrics,
Seattle, WA). For anatomical localization, a pseudocolor image representing
light intensity (from blue [least intense] to red [most intense]) was generated
using the Living Image software and superimposed over the gray-scale reference
image. Bioluminescence within specific regions of individual mice was also quan-
tified using the region-of-interest tool in the Living Image software program
(given as photons s1). For expression of light from the NF-B reporter mice,
180 mg kg1 D-luciferin (Gold Biotechnology, St. Louis, MO) dissolved in 250 l
PBS (pH 7.8) was administered by intraperitoneal injection 5 min prior to
imaging. As a positive control for luciferase gene expression from the NF-B-
RE-luc (Oslo) mice, tumor necrosis factor alpha (TNF-) (2 g per mouse) was
administered by intraperitoneal injection.
Histopathology. Segments of the cecum and the terminal colon of each mouse
were collected at 9 and 14 days postinoculation, rinsed of their content, and fixed
in 10% buffered formalin for microscopic examination. Formalin-fixed tissues
were then processed, paraffin embedded, sectioned at 5 m, and stained with
hematoxylin and eosin (H&E) according to standard techniques. Sections were
examined by light microscopy for the presence of intimately adhering bacteria on
intestinal cells, as previously described (15). Crypt length was also evaluated, and
the lengths of at least four well-oriented crypts were measured for each section.
A nonparametric analysis of variance (ANOVA) with a posteriori comparisons
was performed using commercially available GraphPad InStat v3.06 software
(GraphPad Software Inc., San Diego, CA). P values of 0.05 were considered
significant.
Immunohistochemistry. Snap-frozen colonic tissues, embedded in OCT
mounting medium (VWR BDH, Lutterworth, United Kingdom), were sectioned
using a cryostat to a thickness of 5 m. Sections were mounted on polysine slides
(VWR BDH) and air dried overnight before fixing in acetone at room temper-
ature for 20 min. After air drying for 1 h, sections were rehydrated in Tris-
buffered saline (TBS) for 5 min and then incubated with antibodies against CD3,
CD4, and CD8 (Serotec, Oxford, United Kingdom) at a dilution of 1:50 to 1:100
for 1 h. Sections were gently washed with TBS three times before addition of
biotinylated anti-rat immunoglobulin G (Serotec) at a dilution of 1:200 with 4%
(vol/vol) normal murine serum for blocking (Sera Laboratories International,
Horsted Keynes, United Kingdom) for 30 min. After washing, a 1:200 dilution of
0.1% avidin-peroxidase (Sigma-Aldrich, Dorset, United Kingdom) was added
and left for 30 min before further washing and treatment with diaminobenzadine
substrate (Sigma-Aldrich) for 5 min. The reaction was stopped with excess TBS,
and sections were counterstained with Mayer’s hematoxylin (Sigma-Aldrich) for
30 s, dipped in acid alcohol, and washed in tap water for 5 min. Sections were
dehydrated through an ethanol gradient of 70%, 90%, and 100% solutions (2 min
each), followed by clearing in Histoclear (VWR BDH) and mounting in DPX
(VWR BDH). A control slide using no primary antibody was also made to show
endogenous peroxidase-containing cells. Stained cell populations were counted
in five randomly selected fields per section, and data were expressed as the
number of T cells per 250 m2 of lamina propria.
TABLE 3. Primers
Primer no. Primer name Sequence (533)
1 NleH CRICC169 Fw ATGTTATCACCAGCTCCTGTAAATTTGGGATGTTCATGGAATTCTT
TAACTGTGTAGGCTGGAGCTGCTTCG
2 NleH CRICC169 Rv AATTCTACTTAATACCACTCTGATAAGATCTTGCTTTCCTCCATGA
TAAGCATATGAATATCCTCCTTAG
3 NleH CRICC180 Fw ATGTTATCACCAGCTCCTGTAAATTTGGGATGTTCATGGAATTCTT
TAACGTATACTTATAGGAGGAATC
4 NleH CRICC180 Rv TTAAATTCTACTTAATACCACTCTGATAAGATCTTGCTTTCCTCCAT
GATACACATCCGACCTCGACGAAGC
5 NleH1 EHEC Fw TGAAGGTTGAAATGTATGTTATCGCCATATTCTGTAAATTTGGGA
TGTTCTGTGTAGGCTGGAGCTGCTTCG
6 NleH1 EHEC Rv CACTACACTGGATAAAATTACTAAATTTTACTTAATACCACACTAA
TAAGCATATGAATATCCTCCTTAG
7 NleH2 EHEC Fw ATGTTATCGCCCTCTTCTATAAATTTGGGATGTTCATGGAATTCTT
TAACGTGTAGGCTGGAGCTGCTTC
8 NleH1 EHEC Rv TATCTTACTTAATACTACACTAATAAGATCCAGCTTTCCTCCGTGA
TAAGCATATGAATATCCTCCTTA
9 TNF--Fw ATGAGCACAGAAAGCATGATC
10 TNF--Rv TACAGGCTTGTCACTCGAATT
11 B-actin-Fw AGAGGGAAATCGTGCGTGAC
12 B-actin-Rv CAATAGTGATGACCTGGCCGT
13 IFN--Fw TGAACGCTACACACTGCATCTTGG
14 IFN--Rv CGACTCCTTTTCCGCCTTCCTGAG
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SEM. Intestinal segments were fixed in 2.5% glutaraldehyde and processed for
scanning electron microscopy (SEM) as previously described (14). SEM samples
were examined blindly at 25 kV using a JEOL JSM-5300 SEM [JEOL (UK) Ltd.,
Herts, United Kingdom].
IFA. An indirect immunofluorescence assay (IFA) was used for the detection
of C. rodentium (serotype O152) in formalin-fixed, paraffin-embedded sections as
previously described (14). Tetramethyl rhodamine isothiocyanate-conjugated
donkey anti-rabbit (Jackson ImmunoResearch Europe Ltd., Soham, Cam-
bridgeshire, United Kingdom) secondary antibody was used to visualize O152-
positive bacteria, while DNA of both bacteria and epithelial cells was counter-
stained with Hoechst 33342 (Sigma-Aldrich Co., United Kingdom). Sections
were examined with an Axio Imager M1 microscope (Carl Zeiss MicroImaging
GmbH, Germany). Images were acquired using an AxioCam MRm monochrome
camera and computer processed using AxioVision (Carl Zeiss MicroImaging
GmbH, Germany) and Adobe Photoshop 5.0 and Adobe Illustrator 8.0 software
(Adobe Systems Incorporated, CA).
RNA extraction and quantitative RT-PCR. Total RNA was isolated from
frozen colonic tissue using the RNeasy Plus minikit (Qiagen). All tissues used
were harvested from mice 14 days after oral gavage. Total RNA was measured
using a Nanodrop. TNF- or gamma interferon (IFN-) and -actin mRNAs
were measured by semiquantitative reverse transcription-PCR (RT-PCR) using
primers 9 to 14 listed in Table 3 and the one-step Reverse-iT hot-start kit
(Thermo). The PCR amplification cycle was 20 s at 94°C, 30 s at 60°C, and 60 s
at 72°C for 35 cycles. One microgram of RNA was used for measurement of
TNF- and IFN- transcript levels, and 100 ng of RNA was used for detection
of -actin mRNA. The PCR products were run on a 1% agarose gel alongside
the 100-bp ladder from NEB in Tris-borate-EDTA buffer. GeneTools (Syngene)
was used to conduct densitometric analysis. All TNF-/-actin and IFN-/-actin
ratios were compared between mice infected with wild-type and nleH mutant
bacteria. Statistical analyses were conducted with the one-way ANOVA Bonfer-
roni multiple-comparison test using the GraphPad InStat software (GraphPad
Software Inc., San Diego, CA), as all groups displayed normal distributions.
RESULTS
The NleH T3SS effector homologues. NleH belongs to a
family of T3SS effectors found in diverse enteric pathogens.
EPEC O127:H6 E2348/69 and EHEC O157:H7 EDL933 and
Sakai contain two NleH paralogues, which share 83 to 84%
protein identity. C. rodentium contains only one nleH gene,
which shares 83 and 81% amino acid sequence identity with
EHEC O157:H7 NleH1 and NleH2, respectively. NleH shares
49% amino acid sequence similarity with the serine/threonine
kinases OspG and YspK (Yersinia secreted protein kinase) of
Yersinia enterocolitica.
We employed BLASTp searches of the NCBI protein data-
base using EPEC E2348/69 NleH1 as the query sequence. The
Clustal W2 software (EMBL-EBI) was then used to create a
phylogram of the different homologues (Fig. 1). Two major
clusters were formed, one containing all the NleH effectors and
the other containing closer homologues of OspG, including an
OspG-like effector (90.8% identity to OspG of Shigella) from
FIG. 1. Distance tree of the NleH family. Homologues were iden-
tified using BLASTp searches of NCBI nr protein database with EPEC
2348/69 NleH1 as the query sequence. Protein sequences selected and
analyzed included E. coli O111:H NleH1 (GI:164457622), E. coli
O103:H2 NleH1 (GI:164457632), E. coli O157:H7 EDL933 NleH2
(GI:15801938), C. rodentium NleH (GI:44888794), phage cdtI gp23
(GI:148609405), Y. pseudotuberculosis IP 31758 (GI:153930640), Y.
frederiksenii ATCC 33641 YfreA (GI:77972806), Y. enterocolitica
subsp. enterocolitica 8081 (GI:123442682), Y. intermedia ATCC 29909
YintA (GI:77977119), Y. enterocolitica subsp enterocolitica 8081 YspK
(GI:13442682), S. flexneri OspG (GI:13449175), and E. coli O157:H7
str EC4045 OspG (GI:168711271), as well as EPEC 2348/69 NleH2
(unpublished). The BioEdit software was used to create a ClustalW
alignment. Clustal W2 (EMBL-EBI ebi.ac.uk) was used to create a
phylogram, and TreeView (Bioedit) was used for visualization.
FIG. 2. Course of fecal excretion of EHEC O157:H7 following oral
challenge of 12-day-old calves with wild-type strain 85-170 Nalr or the
85-170 Nalr nleH1 nleH2 mutant. Data represent the mean daily
fecal count (n 
 4 per strain)  standard error of the mean.
FIG. 3. (A) Course of fecal excretion of EHEC O157:H7 following
oral challenge of 6-week-old lambs with wild-type strain 85-170 Nalr or
the 85-170 Nalr nleH1 nleH2 mutant. Data represent the mean daily
fecal count (n 
 5 per strain)  standard error of the mean. (B) CI of
EHEC O157: H7 85-170 Nalr nleH1 nleH2 in lambs infected with an
inoculum containing a 1:1 ratio of wild-type EHEC and the nleH1
nleH2 double mutant. The null hypothesis that CI 
 1 was tested by
a two-sided t test and shows that the mean CI postchallenge is signif-
icantly less than 1 for all time points where it could be calculated
except day 1.
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EHEC O157:H7 strain EC4045. To determine the role of
NleH proteins in vivo, we generated EHEC O157:H7 (strain
85-170) nleH1 nleH2 and C. rodentium (ICC169 and biolu-
minescent strain ICC180) nleH mutants.
The EHEC O157:H7 nleH1 nleH2 double mutant is shed
in greater numbers than the parental strain from orally chal-
lenged calves. To assess the role of NleH in intestinal coloni-
zation of calves by EHEC O157:H7, wild-type and mutant
bacteria were separately inoculated into four 12-day-old Frie-
sian bull calves. Both wild-type and mutant strains colonized
the calves efficiently, and the mutant was excreted at lower
levels than the wild type during the first 4 days. From day 7 the
mutant was shed at higher levels than the wild-type strain, and
the difference became statistically significant (P 	 0.05) from
day 10 onwards (Fig. 2). The course of the fecal excretion of
the wild-type strain was consistent with previously observed
patterns (10, 33, 37).
Contribution of NleH1 and NleH2 to colonization of con-
ventional 6-week-old-lambs. A 6-week-old lamb model was
next used to compare the persistence of an E. coli O157:H7
nleH1 nleH2 double mutant and the isogenic wild-type
strain. The ability of the mutant to establish itself and persist in
lambs was investigated by monitoring the viable counts recov-
ered in fecal pellets collected per animal. When given as a
single inoculum, the wild-type E. coli O157:H7 isolate pro-
duced the classical shedding pattern in lambs, as described
previously (5, 42), persisting in relatively high numbers during
the early stages of infection and then declining by day 11
postinoculation (Fig. 3A). The nleH1 nleH2 mutant dem-
onstrated a similar shedding pattern, except that positive fecal
samples were noted only until day 12 postinoculation (Fig. 3A).
When both isolates were administered in the same inoculum,
the wild type persisted for 4 days longer than the nleH1
nleH2 mutant (data not shown). The mean CI was signifi-
FIG. 4. Anatomical localization of luminescent wild-type C. rodentium ICC180 and nleH strains during in vivo infection of mice. Images were
acquired using an IVIS50 system and displayed as pseudocolor images of bioluminescence. The variations in color represent light intensity at a
given location, with red being the most intense light emission and blue being the weakest signal. The colored scale to the right indicates relative
signal intensity in photons s1cm2 sr1. At each time point postgavage, mice were imaged with an integration time of 1 min.
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cantly less than 1 for all time points where it could be calcu-
lated except day 1 (Fig. 3B), demonstrating that the wild-type
strain outcompeted the nleH1 nleH2 mutant in the ovine
model.
Contribution of NleH to colonization in the C. rodentium
murine model. We followed the anatomical localization and
pathogenic burden using BLI and viable counts in stools of
mice infected with either wild-type or nleH C. rodentium.
Using BLI, we observed that both the wild-type and mutant
strains colonized the cecal patch and rectum by day 3 to 4
postinfection. After adaptation to the in vivo environment (day
6 to 7), the entire distal colon was then heavily infected. Clear-
ance began by day 10, at which point light intensity decreased.
By day 14 the gastrointestinal tract had mostly cleared the
infection (Fig. 4). Viable counts of bacteria in stool mirrored
the results obtained by BLI; no significant differences in viable
bacterial counts of the wild-type and nleH mutant strains
were seen (Fig. 5A). However, the nleH C. rodentium mutant
was significantly out competed by the wild-type strain in a
mixed infection (Fig. 5B).
NleH does not affect A/E lesion formation and T-cell infil-
tration in the C. rodentium murine model. The hallmarks of C.
rodentium infection include induction of extensive colonic hy-
perplasia and influx of T cells into the colonic lamina propria.
Histological examination and measurement of crypt length did
not reveal any differences between the parent and mutant
strains (data not shown). Immunohistochemistry, performed to
investigate the influx of CD3, CD4, and CD8 T cell subsets
into the colonic lamina propria at 14 days postinoculation,
revealed that although the nleH mutant-infected animals
showed slightly fewer CD3- and CD4-positive T cells in the
lamina propria, no significant differences were observed be-
tween animals infected with the mutant or wild-type C. roden-
tium strains (data not shown). Immunofluorescent staining
with anti-O152 and SEM analysis at day 9 or day 14 postin-
oculation did not reveal any differences between the wild-type
and nleH C. rodentium strains (Fig. 6).
NleH influences NF-B levels and expression of TNF- in
vivo. A recent study has shown that OspG inhibits degradation
of IB and hence activation of NF-B and that a Shigella ospG
mutant induces a stronger inflammatory response than the
wild-type strain after inoculation of rabbit ileal loops (20). In
order to determine if NleH influences activation of NF-B in
vivo, we infected NF-B-RE-luc reporter mice with C. roden-
tium wild-type strain ICC169 or ICC169 nleH; mice inocu-
lated with the commensal E. coli strain ICC299 (Table 1) or
PBS were used as controls. The number of nleH mutant bac-
teria shed from this mouse strain was similar to that of the wild
type (data not shown). No significant differences in whole-body
(including chest, neck, abdomen, and rectum) luminescence
counts were recorded by live imaging, at any time point, be-
tween PBS-gavaged animals and those gavaged with wild-type
C. rodentium, the nleH mutant, or the commensal E. coli. On
day 14 postchallenge, we recorded luminescence counts in
different organs. While no significant difference in the lumi-
nescence counts was seen in the mesenteric lymph nodes,
spleens, and ceca of the different mouse groups (Table 4),
there was a significant (P 
 0.0024) 2.5-fold increase in the
signal from the colon in mice infected with the wild-type C.
rodentium compared to those inoculated with C. rodentium
nleH, E. coli ICC299, or PBS (Fig. 7A and B). This difference
was similar to the three- to fourfold-increased luminescent
signal seen after mice were inoculated with TNF- as a positive
control (data not shown).
As NF-B induces the transcription of many proinflamma-
tory cytokines such as TNF- and IFN-, we compared the
levels of their transcripts in uninfected mice and mice infected
with either wild-type or nleH mutant C. rodentium. RNA
extracted from distal colons of mice was subjected to semi-
quantitative RT-PCR. Transcript levels were quantified as a
FIG. 5. (A) Course of fecal excretion following oral challenge of
groups of six 6- to 8-week-old C57BL/6 mice with either wild-type C.
rodentium ICC180 or the nleH mutant. (B) Mean CI of C. rodentium
nleH in mice infected with an inoculum containing a 1:2 ratio of
wild-type C. rodentium and the nleH mutant. The null hypothesis that
CI 
 1 was tested by a two-tailed nonparametric Wilcoxon test and
showed that the mean CI postchallenge is significantly less than 1 for
all time points where it could be calculated.
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ratio of TNF- or IFN- to -actin. This revealed that the
levels of TNF- mRNA were significantly higher in tissues
extracted from infected mice than in those from uninfected
control mice. Mice infected with the wild-type C. rodentium
had significantly higher TNF- transcript levels than those
infected with the nleH mutant (Fig. 8). The levels of IFN-
transcript were comparable in all mouse groups (data not
shown).
DISCUSSION
Many gram-negative bacterial pathogens use T3SS effectors
to modulate host cell signaling pathways. Effector proteins can
trigger local (e.g., alteration in the cytoskeleton) or systemic
(e.g., immune response) changes. Colonization of the mucosal
surface requires temporal modulation of the host immune sta-
tus. While downregulation of innate immunity might aid the
pathogen to launch an infection and to reach a critical mass,
activation of the immune system might assist the pathogen in
its competition with the resident gut microflora. It is therefore
not surprising that pathogenic bacteria are equipped with vir-
ulence factors which have antagonistic immune modulation
activities. Indeed, in a recent report Lupp et al. demonstrated
that C. rodentium population expansion in vivo is mediated by
an inflammatory response that disrupts the endogenous intes-
tinal microbiota (22). In contrast, using polarized culture mod-
els, Ruchaud-Sparagano et al. have shown that EPEC inacti-
vates innate immune responses in vitro (32).
In this study we investigated the role of NleH in coloniza-
tion, competitiveness, and activation of the NF-B pathway in
vivo. EPEC O127:H6 E2348/69 and EHEC O157:H7 EDL933
and Sakai contain two, almost identical, copies of nleH, while
C. rodentium harbors only a single nleH gene. The functional
consequences of this gene duplication are not known. Inter-
estingly, a recent shotgun sequencing of a number of EHEC
O157:H7 isolates has shown that they contain, in addition to
nleH, a gene whose product shares 90.8% sequence identity
with OspG (NCBI BLASTp).
Investigation of the contribution of NleH toward coloniza-
tion and competitiveness of EHEC O157:H7 in bovine and
ovine hosts, which are important animal reservoirs of the
pathogen, showed that the EHEC O157 nleH1 nleH2 dou-
ble mutant was shed in greater numbers than the parental
strain from orally challenged calves, significantly from day 10
postinoculation. The precise effect of deleting nleH on factors
or regulatory mechanisms involved in EHEC O157:H7 coloni-
zation in bovine intestines remains to be investigated. In single-
infection studies with lambs, there was no statistical difference
in shedding after oral inoculation with the same strains. How-
ever, CIs measured following oral inoculation of lambs with a
mixture of wild-type EHEC O157:H7 and the nleH1 nleH2
double mutant revealed that the mutant was significantly out-
competed. The reasons for the different phenotypes observed
in the bovine and ovine models are currently not known. How-
ever, these results show that effector proteins might have dis-
similar or even opposite functions in different hosts.
In order to determine the contribution of NleH to infection
with C. rodentium, we mutated nleH in the wild-type ICC169
and luminescent ICC180 strains. Deletion of nleH from C.
rodentium had no significant effect on in vivo tissue tropism,
bacterial burden, colonic hyperplasia, or infiltration of CD3,
CD4, and CD8 cells to the lamina propria. A subtle phe-
notype was recently reported for C. rodentium nleH in single
infection, as expansion of the mutant population in vivo lagged
behind that of the wild-type population during early stages (6
days postchallenge), although at later stages (10 days) the
mutant and wild type colonized at comparable levels (11). The
reasons for the different results might be due to the mouse
status (i.e., composition of the normal gut flora), preparation
of the inocula, or bacterial strains. Importantly, we found that
in a mixed infection the nleH mutant was significantly outcom-
peted by the wild-type strain, suggesting that expression of
NleH increases the bacterial fitness in vivo. This could explain
the need for conservation and multiplicity of the gene in
EHEC and EPEC strains.
As we did not observe any difference in colonization and
clearance dynamics, hyperplasia, and T-cell infiltration be-
tween the wild-type and nleH mutant strains, NleH appears
to have a local rather than systemic role, possibly in displacing
FIG. 6. Interaction of wild-type C. rodentium strain ICC180 and its nleH mutant with the colonic epithelium in vivo. (A) At day 9
postchallenge, typical foci of intimately adherent bacteria (arrows) were observed on H&E-stained sections, accompanied by a highly disorganized
epithelium. IFA staining revealed these bacteria to be of the O152 serotype (arrowheads), corresponding to C. rodentium serotype. These foci of
intimately adherent bacteria were confirmed to be A/E lesions by SEM. Neither O152-positive bacteria nor A/E lesions were observed on sections
or samples derived from uninfected mice. (B) No adherent bacteria were observed in the colons of mice infected with ICC180 and the ICC180
nleH mutant at day 14 postchallenge, although crypt hyperplasia was still present. For the IFA panel: Hoechst 33342 (blue, false color), DNA;
tetramethyl rhodamine isothiocyanate (intense blue, false color), O152-positive bacteria. Representative micrographs are shown. Bar, 20 m
(H&E and IFA) or 100 m (B).
TABLE 4. Specific bioluminescence from each organ at harvest
Inoculum
Specific bioluminescence (mean  SD) from:
Cecum Mesenteric lymph nodes Spleen Colon Intestines
ICC169 2.59  105  8.00  104 2.35  106  9.47  105 9.25  104  2.29  104 1.41  106  2.92  105 1.72  106  4.69  105
nleH mutant 1.80  105  9.89  104 2.75  106  1.26  106 2.12  105  2.38  105 5.69  105  2.53  105 2.08  106  1.04  106
PBS 3.61  105  8.78  104 3.02  106  8.61  105 8.33  104  1.71  104 6.34  105  2.37  105 1.53  106  6.35  105
Commensal
strain
2.69  105  4.42  104 2.58  106  8.11  105 1.39  105  2.81  104 5.02  105  1.03  105 2.38  106  4.27  105
VOL. 76, 2008 ROLE OF NleH IN EHEC AND C. RODENTIUM INFECTION 4811
the normal gut flora. Considering that both NleH (C. Hemra-
jani, unpublished data) and OspG (20) are protein kinases and
share a high level of sequence identity, we investigated, using
reporter mice, if NleH plays a role in activation of the NF-B
pathway. Unexpectedly, we found lower activation of NF-B in
the colon in mice infected with the C. rodentium nleH mutant
than in those infected with the parental wild-type strain. Con-
sistent with these results, we found lower colonic levels of
TNF- at 14 days postchallenge in mice infected with the
nleH C. rodentium mutant than in those infected with the
wild-type strain, while no difference was recorded for IFN-.
These data suggest that NleH triggers local activation of NF-
B, which in turn leads to a differential increase in the levels of
proinflammatory cytokines.
Collectively these results demonstrate that the role of NleH
during infection is host specific. NleH, one of the core and
conserved T3SS effectors in A/E pathogens, is likely to work
with other effectors in optimizing the level of local gut inflam-
matory responses and the relationship with the endogenous gut
flora for the benefit of the pathogen.
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